683 Capital Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
DTC
EC
FCM
5VM
PM
BG
WP
IC
683 Capital Management's TECX Position: Q1 2025 in Review
683 Capital Management sold out of Tectonic Therapeutic (TECX) in Q1 2025, closing a stake of 14,027 shares — an estimated $648K sold.
683 Capital Management first reported a position in TECX in Q4 2024 and held it in 1 quarter. The position peaked at $648K in Q4 2024. 78 funds tracked by Wall St. Rank hold TECX as of Q1 2025.
- 683 Capital Management reported no remaining Tectonic Therapeutic position as of Q1 2025 after selling out during the quarter.
- 683 Capital Management sold 14,027 Tectonic Therapeutic shares in Q1 2025, an estimated $648K.
- 683 Capital Management first reported a position in Tectonic Therapeutic in Q4 2024 and held it in 1 quarter.
- 683 Capital Management's Tectonic Therapeutic position peaked at $648K in Q4 2024.
- 78 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2025.
Based on 683 Capital Management's 13F filing for Q1 2025, filed 15 May 2025.